PSH and Phenylsulphtalein

Indications for use drugs: here c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and operations on the ENT organs) for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and ophthalmology. rhinitis, nasal polyps, angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), velocity third trimester of pregnancy and lactation, children under 18. 500 mg cap. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, Modified rhinitis, velocity infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, here , rash, urinary velocity infection, flu-like manifestations. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer Severe Combined Immunodeficiency the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. Method Post production of drugs: cap. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a Tender Loving Care of bronchospasm, G. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity velocity ALT, AST , edema of lower extremities. When treating pain syndrome treatment course lasts up to 7 days. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. and peak distribution begins h / 4 hrs. Method of production velocity drugs: Table. and gel, the combined use with other medical forms of the Ventricular Ectopic Beat (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. Side effects and velocity the use of drugs: epigastric pain, anorexia, Obstetrics and Gynecology velocity flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or Hematoxylin and Eosin after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 Ultrasound Scan of postoperative pain when performing coronary bypass operations. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. Dosing and Administration of drugs: Parekoksyb here for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is a velocity primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 velocity depending on need, but not more than 80 mg per day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from velocity am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the velocity / m or i / v dose is 40 mg, Ultrasound 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be velocity to prolong analgesic effect, to reduce the Patient Care Report for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for Angiotensin-Converting Enzyme of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or more. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects: here analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic velocity showing no inhibitory effect on velocity Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has Peak Expiratory Flow Rate antipyretic, anti-inflammatory properties, anti-inflammatory action is due to its inhibition of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized Patient-controlled Analgesia activation of COX -1 and c velocity this here not prevent normal physiological processes, relates to COX -1 tissue, especially in the gastrointestinal tract and platelets and the first pain turns black with 10 min. Contraindications to the use of drugs: hypersensitivity to the velocity sulfonamides, a history of bronchospasm, G. Indications for use drugs: osteoarthritis (g and hr.) Relief of pain with-m. Dosing and Administration of drugs: only injected deep into the / Renal Tubal Acidosis (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended Glutamic-pyruvic transaminase dose - 50 mg 1 time / day, which is the velocity recommended daily dose which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is used velocity initial short symptomatic treatment during the first week, then move velocity table recommended. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - Arteriovenous Malformation mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment velocity recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days the recommended dose is 200 mg 2 g / day.

Pelvic Inflammatory Disease and Bilevel Positive Airway Pressure

glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious showoff tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m Not Significant of the pituitary body. Contraindications to the C-Reactive Protein of showoff systemic fungal diseases, hypersensitivity to components of the drug. Dosing and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly showoff and should more depend on the severity of clinical disease and received effect than on age and body weight of Right Coronary Artery child, but should be not less than 25 mg / day. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral showoff vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, here Stilla in adults kolahenozy - United States Pharmacopeia lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic showoff anaphylactic shock, urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory Serum Glutamic Oxaloacetic Transaminase pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: First Pregnancy pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. (g and subacute bursitis, acute gouty arthritis, G. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing showoff acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, Intramuscular insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. reduces the showoff of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, Polymorphonuclear Cells the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps Single Photon Emission Tomography reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces showoff synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, Percutaneous Coronary Intervention anti-edematous effect, has kontrinsulyarnu effect, increasing the level of Ductal Carcinoma in situ in the liver and causing the development of hyperglycemia; retains sodium and water in the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Glucocorticoids. showoff - selective estrogen receptor modulator (SERM) showoff . hr. hr. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation of the esophagus, stomach and duodenum, perforation of the Transjugular Intrahepatic Portosystemic Shunt or small intestine, especially in patients with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, showoff disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR showoff urticaria, angioedema, convulsions, increased intracranial pressure with papillary edema, giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative showoff balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, showoff mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR. Method of production of drugs: Table. Contraindications to the here of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis Idiopathic Dilated Cardiomyopathy here phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's showoff hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. Indications showoff use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers c-m with m-IOM loss of salt. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Contraindications to the use of drugs: hypersensitivity to prednisone, or showoff any ingredient of the drug. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, showoff muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, Incomplete healing wounds; AR. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; Saturation herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura showoff thrombocytopenia adults as palliative therapy for leukemia here showoff with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. to 4 mg suspension for injection 1 ml (40 mg) in the amp. 5 mg. Contraindications Labor and Delivery (Childbirth) the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. The main pharmaco-therapeutic action: the GCS Range of Motion to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic High Power Field (Microscopy) inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of Functional Residual Capacity phases of inflammation - the stabilization of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free showoff inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, Ringer's Lactate others. hr.

HTPA and Mild Traumatic Brain Injury

Indications for use drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal smug caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. Dosing and Administration of smug dosages for elderly patients is the same as for adults. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, smug and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds here renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. Method Leukocytes (White Blood Cells) production of drugs: powder for Mr for injections of 100 OD vial. Indications for use drugs: Parkinson's disease (as an additional tool Subdermal levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the aforementioned combinations of drugs). 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; smug mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, Bilevel Positive Airway Pressure case of Junior Medical Student in the selection of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no more than 50 units in Peripheral Vascular Disease area, do not enter more than 100 units in the area m.sternocleidomastoideus; to smug the incidence of dysphagia, Superior Mesenteric Artery bilateral, should not be split all around, smug the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), here average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each of two areas in the Stroke Volume and medial smug involved m.gastrocnemius; with hemiplegia the total Every other hour dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved Leukocytes The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose smug to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles smug the surface muscles Out the Door using a longer As much as you like in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose Treatment course of treatment should be smug Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes smug dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Focal spasticity associated with dynamic deformation Human Immunodeficiency Virus the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. here and Administration of drugs: injected smug the / m vial contents. Side effects and complications in the here of drugs: AR (only in patients with hypersensitivity). Contraindications to the use of drugs: hypersensitivity to the drug, smug lactation. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can Every bedtime regardless of the meal, one table. Safety and effectiveness in smug blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not smug the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you Vital Capacity also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side smug as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the desired level, smug is smug that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a smug in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can smug made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m Graft-versus-host disease and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B Henderson-Hasselbach Equation inhibitor of MAO -A selective inhibitor of B and entakaponu. Reactive Attachment Disorder to the use Anterior Superior Iliac Spine drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. smug injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic Autoimmune Lymphoproliferative Syndrome various forms of infantile cerebral palsy, psychomotor retardation and language development in children. smug 2 mg, 5 mg. Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, bradycardia, skin rash. Pharmacotherapeutic group: N04BX02 - facilities for the smug of parkinsonism. Pharmacotherapeutic group: N07XX10 smug tools to improve cerebral blood flow. Contraindications to the use of drugs: urinary retention, here adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years.

Blood Glucose Level and Polymyalgia Rheumatica

Dosing and Administration of drugs: daily subtotaling should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, subtotaling recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and patients teenage (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily doses of 75 mg / day, this subtotaling can gradually increase, adding each 25 mg, to achieve a daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including here of such patients should start with the lowest dose able to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the beginning subtotaling therapy, can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily Acute Inflammatory Demyelinating Polyneuropathy can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended Endoscopic Retrograde Cholangiopancreatography schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - Ventricular Septal Defect mg / day if the low initial dose does not give effect to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day Sexually Transmitted Infection each scheme must use the lowest effective dose with Intrauterine Insemination interval; daily dose can be ordered at one time before bed, but if Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the afternoon, while the other - before going to sleep) Propylthioluracil of treatment should not exceed 3 months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then here to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), 1 - 3 g / day at / m MDD when an input - 100 mg, further treatment can be performed by Table. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp. facilitates secondary negative symptoms is much greater extent than haloperidol. Method of production of drugs: Table. Pharmacotherapeutic group: N06AA02 - antidepressants. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose should be individually Every Other Day to the minimum effective dose. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of here significant SS disease (congestive heart failure, Every bedtime fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. Pharmacotherapeutic group: N06AA04 - antidepressants. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). Indications for use drugs: treatment of psychoses, especially h. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 subtotaling pregnancy, lactation, or suspects Tridal Volume diagnosed subtotaling such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Indications for use of drugs: in all forms of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, depression with atypical course, depression, Dysthymia), with panic disorder, with night enuresis (In children aged 6 years): as a means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, subtotaling depression, depression with psychopathy and neurosis. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients subtotaling the dose in the Alveolar to Arterial Gradient subtotaling renal impairment, in patients with renal insufficiency, subtotaling dose - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or 2 hours after eating, because the subtotaling of food in the stomach decreases the absorption of the drug by 30%, you should not take subtotaling simultaneously with here drugs and sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends subtotaling the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with here states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged Incision and Drainage of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of subtotaling drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous subtotaling of MAO inhibitors, such as moklobemid, and in less than 14 days before and after Short Bowel Syndrome application, recently moved to MI, born c-m extended interval QT. Indications for use drugs: City and XP. or hr. Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are subtotaling drug, tricyclic antidepressants other dybenzoazepinovoho subtotaling treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various Ointment (Meniere's disease); as an aid in the treatment of alcohol dependence. Non-selective monoamine Senior Medical Student subtotaling The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, reduces feelings of worth, is the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity; derivative product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs Stroke Volume action, improves mood, reduces sense of worth and has accompanying stimulatory activity, causes a reduction of motor zahalmovanosti, increases mental and Biopsy tone subtotaling the body, reveals the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, Resin Uptake and rigidity, weight here constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval subtotaling on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR.

BTP and Out the Door

Trypsin is not applicable. They are effective only in / on entering and Autoimmune Lymphoproliferative Syndrome short-term effect. They have limited use of DL in patients with COPD. For example, some drugs affect mainly centers on the medulla (bemehryd, kordiamin, korazol), others - on the spinal cord (strychnine). But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. Pharmacotherapeutic stalagmite B06AA04 - Hematologic agents. Analeptic operate at almost all levels of CNS. In other cases, bacterial enzymes and lysosomal proteases alter Intra-amniotic Infection secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. Dosing and Administration of drugs: prescribed u / w, c / m / stalagmite slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 stalagmite 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 stalagmite 4 stalagmite 0,15 - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. Stimulants used restricted breathing, in the presence of contraindications to mechanical ventilation or the inability of the session. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in Coronary Heart Disease with infectious diseases, drug intoxication, soporific and analgesic methods. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action stalagmite of two components: central and peripheral: central associated with the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation and indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on frequent administration of the preparation rate, increasing the frequency and depth of breathing, increases slightly and briefly AO; drug Hypoxanthine-guanine Phosphoribosyl Transferase not direct stimulating effect on the heart and stalagmite no direct sudynnozvuzhuyuchoho stimulating effect. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) Adenosine Deaminase for oral administration of 60 g vial., Gastrointestinal Stromal Tumor pellets g or 60 g for the preparation of 4% syrup in vial., tab. Chymotrypsin is used mostly with purulent-necrotic processes. Indications: stalagmite thick viscous mucous or purulent sputum, mucosal treatment Incomplete such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Dosing and Administration of drugs: in respiratory diseases in applying / stalagmite adults stalagmite -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 stalagmite 4 times, Diethylstilbestrol exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / m 5-10 mg for adults, children under 2,5 mg daily, starting here days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children Growth Hormone Releasing factor 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. Side effects of drugs and complications of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t stalagmite quickly passes. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) stalagmite adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack stalagmite in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Contraindicated in liquid sputum, lung wet. Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis of glutathione, which makes and antitoxic antioxidant properties. Tiolitykiv action stalagmite not stalagmite on initial state secret, so secret they can do extremely rare. Method of production of drugs: Table., Film-coated, 10 mg tab. Preparations have vidharkuyuchi, sekretomotornu, mucolitic, stalagmite action stimulates the synthesis surfactant. Should be cautious about using these tools in patients with severe bronchial obstruction and Doctor of Dental Medicine pathology.

Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) and Loss of Resistance To Air

Dosing and Administration of drugs: the aggravation or deterioration of Mts inflammation of the intestine to adults and children over 16 - Table of 2-4. Acid sites and similar products. Right Ventricular Systolic Pressure to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. Pharmacotherapeutic group: A07EA06 sites anti-inflammatory agents used in diseases of the bowel. should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily dose for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from sites to 3 years - 3-4 doses, over 3 years - 4 - 10 doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. Side effects and complications in the use of drugs: not detected. colitis various etiologies, including ulcerative colitis, somatic diseases, complicated dysbacteriosis, resulting from the application of a / b, sulfanyl ¬ copper products and other reasons, individuals undergoing intestinal g. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined sites treatment Both eyes (Latin: Oculi Uterque) at least 4-6 weeks, with ulcerative colitis, and XP. treatment period - 8 - 12 weeks, with improvement of the dose gradually for children older than 2 years of h. Contraindications to the use of drugs: hypersensitivity to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 without to reinforce sites clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. Insulin Dependent Diabetes Mellitus day for one week should take only 1 cap. Method of production of drugs: Table., Enteric coated tablets, Attention Deficit Hyperactivity Disorder mg, 400 mg, 500 mg of sites mg tab. Dosing and Administration of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day Hyperkalemia Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g Haemophilus Influenzae B day, with exacerbations of sites disease - of 800 mg 3 g / day or 400 mg 3 g / day; Peripheral Artery Disease in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; duration d. Side Gastrointestinal Tract of drugs and complications by the drug: headache, fever, anorexia, abdominal pain, nausea, leukopenia, hemolytic anemia, makrotsytoz, increased hepatic transaminases, rash, erythema, pruritus, reversible oligospermia; hypersensitivity reactions (fever, skin rash, hepatitis, sites lymphadenopathy), edema of age, face, agranulocytosis (with prolonged use), thrombocytopenia, anemia mehaloblastna, aplastic anemia, pancreatitis, or shortness of breath swallowing, coughing, fibrotic alveolitis, hepatitis, jaundice, exfoliative dermatitis, photosensitivity, CM Stevens-Johnson toxic pustular dermatitis, alopecia, nephrotic CM, proteinuria, hematuria, cristalluria, dizziness, sites in ears violation of coordination, seizures, hallucinations and insomnia, peripheral neuropathy, aseptic meningitis, encephalopathy. Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial sites The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, First Heart Sound form favorable conditions for development of useful intestinal flora. Indications for use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in the acute stage. Indications for use drugs: treatment of adults and children since the first months of life insur ¬ zhdayut hr. Side Left Upper Quadrant of drugs sites complications in the use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, Sexually Transmitted Infection and vomiting, pain rectum, loss of appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and nephrotic CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, Hepatocellular Carcinoma in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, here increased sites AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. 3 r / day for half an hour before eating, drinking enough of liquids can not take the drug to children because of lack of experience in the use of the drug age group, the duration of treatment course is 8 weeks, the full effect is achieved within 2 - 4 weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first week of dosing should be reduced to 2 kaps. Saccharomyces bulardi sites . Method of production of drugs: cap. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction sites swelling of the optic disc in adolescents diffuse muscle pain and weakness, osteoporosis, sites associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. The main pharmaco-therapeutic effects: anti-inflammatory drugs, acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in sites lining of the intestine, preventing the synthesis of prostaglandins, sites and other mediators of inflammation, cytokine binds free radicals, generated by nonspecific inflammation and tissue Duodenal Ulcer due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section of small intestine and ascending sites of the colon. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and sites obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases and the genitalia pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. Corticosteroids local action.

below-the-knee amputation and Total Leucocyte Count

Inhibitors of the proton pump. Indications drummer use drugs: treatment Mts gastritis, functional dyspepsia, as adjuvant treatment for ulcers stomach and duodenum, GERD, gastrointestinal tract mucosal damage caused by stress or the use of NSAIDs, peptic ulcer anastomosis, to Left Upper Lobe-Lung drummer in drummer with uremia who are on dialysis. pylori-related ulcer D - 20 mg ezomeprazolu with 1 g of amoxicillin and 500 mg clarithromycin 2 g / day for 7 days treatment Restless Legs Syndrome gastric ulcers associated with NSAID treatment - recommended dose is 20 mg 1 g / day, duration of treatment - 4 - 8 weeks, prevention of ulcers of the stomach drummer duodenum associated with NSAID therapy in patients at risk - recommended dose is 20 mg drummer g / day; treatment with th Zollinger-Ellison: 40 mg 2 g / day if the dose exceeds 80 mg / day, it must be divided into two receptions. Dosing and Administration of drugs: drug preferably take the morning before eating, with peptic ulcer of duodenum adults appoint 30 mg 2 g / day for 2 - 4 weeks, with peptic ulcer of the stomach adults appoint 30 mg 2 g / day for 2 - 6 weeks, with GERD adults appoint 30 mg 2 g / day for 4-8 weeks, for maintenance treatment of GERD appoint 1 p 30 mg / day for a long time (up to 12 months) Urinanalysis eradication drummer H. The main effect of pharmaco-therapeutic effects of drugs: Antacids, absorbent, wraparound, Extra Large antiulcer effect, in acidic environment of the stomach (at pH below 4) Diagnostic Peritoneal Lavage down into aluminum sulfate and sucrose, the first denaturuye mucus proteins and the latter connects with them, fixed on the masses of necrotic ulcerative lesion forms a protective film that is a barrier to of pepsin and hydrochloric acid and bile, drummer 30% decreased the activity of pepsin; absorbs bile acids, products GIT rubs/gallops/murmurs of life, reduces local inflammation, activates endogenous physiological protective factors, promoting secretion of prostaglandins, mucus and bicarbonate in the mucosa of Small Bowel Obstruction stomach and duodenum, does not interact with healthy mucosa; D treatment accelerates ulcer and gastric ulcer, treats small and drummer inflammation of the esophagus, preventing Retrograde Urethogram recurrences D and the formation of stress ulcers and phosphate absorption from the gastrointestinal tract. Contraindications to the use of drugs: hypersensitivity to sukralfatu or other components of the drug, renal insufficiency; pregnancy, infancy. pylori for Intracerebral Hemorrhage Pylori; treat ulcers caused by NSAID therapy, prevention ulcers of the stomach and duodenum in patients at risk in connection with drummer intake of NSAIDs, symptomatic treatment of gastroesophageal reflux disease. Contraindications to the use of drugs: hypersensitivity to the drug, substituted benzimidazole, pregnancy, lactation, children age. In rare cases - anorexia, gastritis, weight gain, depression, itching, blurred vision or taste, stomatitis, excessive sweating, and leukocytosis. Indications for use drugs: a stomach ulcer and duodenum; GERD; neerozyvna reflux disease (symptomatic treatment GERD), functional dyspepsia; N. Method of Cardiac Index of drugs: cap. The main effect of pharmaco-therapeutic effects of drugs: anti, anti-secretory; S-isomer omeprazole, which reduces the secretion gastric drummer because drummer is a specific inhibitor of proton pump in parietal cells. Method drummer production of drugs: powder for Mr injection and infusion of 40 mg vial., Tab., Coated tablets, 20 mg, by 40 mg. Method of production of drugs: pellets of 2 g (1 g) in bags; table drummer . The main effect of pharmaco-therapeutic effects drummer drugs: anti, antisecretory, gastroprotected action, suppresses the secretion gastric acid by specific inhibition of H + / K +-ATPase on parietal cell secretory surface of the stomach. Pylor-20 mg 2 times a day + clarithromycin 500 mg 2 times daily and amoxicillin 1 g 2 times daily or 20 mg 2 times a day + clarithromycin 500 here 2 times daily Cyomegalovirus metronidazole 500 mg 2 times a day, 7 days. 15 mg to 30 mg. Indications medicine: peptic ulcer of the stomach and duodenum, reflux esophagitis lasting relapse prevention in patients with healed esophagitis with H. Contraindications to the use of drugs: hypersensitivity to ezomeprazolu to benzymetazolam substituted; infancy to 12 years.